ESTRO 2025 - Abstract Book

S855

Clinical - Gynaecology

ESTRO 2025

Conclusion: The alteration in risk stratification introduced by the new classification system significantly impacts overall survival. Patients classified as low or intermediate risk under the new system demonstrate a significantly improved prognosis compared to those in the intermediate-high or high-risk groups.

Keywords: Endometrial Cancer, New Molecular Classification